便calprotectin从从克罗恩病患者的乳房结节术输出
Jung-Bin Park1, Jeongkuk Seo2, Ji Eun Baek1,3
1Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
BMC gastroenterology
|February 13, 2025
概括
排泄物中产生的便calprotectin (FC) 能够有效地监测克罗恩氏病 (CD) 患者手术后的小肠炎症. 这种生物标志物在区分活跃疾病与缓解方面具有很高的准确性,有助于术后护理.
科学领域:
- 胃肠病学 胃肠病学
- 炎症性肠道疾病研究研究
- 生物标志物发现发现
背景情况:
- 便calprotectin (FC) 是克罗恩氏病 (CD) 活动和术后监测的关键生物标志物.
- 它在患有大肠切开术的患者中用于评估小肠炎症的实用性尚不清楚.
研究的目的:
- 为了评估便calprotectin (FC) 在结肠静脉切除输出作为一个预测器的术后小肠炎症在CD患者.
- 为了比较治疗点 (POC) 和ELISA方法的诊断准确性,用于FC测量.
主要方法:
- 在2015-2022年期间,对101名患有结核病的患者进行了回顾性分析,这些患者进行了结核病和FC测量.
- 同时进行FC测试,并进行成像和/或内镜研究以验证.
- 通过治疗点 (FC-POCT) 和ELISA (FC-ELISA) 方法测量FC.
主要成果:
- 在CD患者中,炎症小肠和非炎症小肠之间的FC水平存在显著差异 (FC-POCT和FC-ELISA的P<0.001).
- 确定了最佳的FC截止值:FC-POCT的63.3微克/g (AUC0.90) 和FC-ELISA的40.1微克/g (AUC0.89).
- 在FC-POCT和FC-ELISA之间诊断准确度没有显著差异 (P = 0.692).
结论:
- 结节管输出FC是监测CD患者术后小肠炎症的敏感和特定生物标志物.
- 使用POC或ELISA进行FC测试,有助于管理患有结节切开术的CD患者.
- 这一发现支持使用FC作为一个有价值的工具在术后监测CD.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
301
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
301
Inflammatory Bowel Disease II: Crohn's Disease
166
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
166
Inflammatory Bowel Disease V: Surgical Management
95
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
95
Inflammatory Bowel Disease I: Ulcerative Colitis
122
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
122
Serum Laboratory Studies, Stool Test, Breath Test
297
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
297
Drugs for Treatment of Ulcerative Colitis in IBD
118
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
118


